*Refers to the latest 2 years of omaha.com stories. Cancel anytime. Hers examines the weight-loss injectables market across ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

As part of our series In Good Health, we discuss these new medications and the falling rate of obesity.

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...

CNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...